These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22945242)

  • 1. Huge aneurysm of the ascending aorta in a patient with adult-type Pompe's disease: histological findings mimicking fibrillinopathy.
    Goeber V; Banz Y; Kaeberich A; Carrel T
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):193-5. PubMed ID: 22945242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.
    Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT
    Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
    Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
    Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased aortic stiffness in glycogenosis type 2 (Pompe's disease).
    Nemes A; Soliman OI; Geleijnse ML; Anwar AM; van der Beek NA; van Doorn PA; Gavallér H; Csajbók E; ten Cate FJ
    Int J Cardiol; 2007 Aug; 120(1):138-41. PubMed ID: 17084921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional anesthetic techniques are an alternative to general anesthesia for infants with Pompe's disease.
    Walker RW; Briggs G; Bruce J; Fletcher J; Wraith ED
    Paediatr Anaesth; 2007 Jul; 17(7):697-702. PubMed ID: 17564654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse.
    Kamphoven JH; de Ruiter MM; Winkel LP; Van den Hout HM; Bijman J; De Zeeuw CI; Hoeve HL; Van Zanten BA; Van der Ploeg AT; Reuser AJ
    Neurobiol Dis; 2004 Jun; 16(1):14-20. PubMed ID: 15207257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilative arteriopathy in metabolic myopathies, particularly Pompe's disease.
    Finsterer J
    Acta Neurol Belg; 2012 Mar; 112(1):15-8. PubMed ID: 22427284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pompe's disease: ultrastructural alterations of muscle tissue in parents.
    Pellegrini G; Mosca G; Cerri C
    Acta Neurol Scand; 1978 Mar; 57(3):216-22. PubMed ID: 276244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocrine glands in Pompe's disease. Report of two cases.
    Hui KS; Williams JC; Borit A; Rosenberg HS
    Arch Pathol Lab Med; 1985 Oct; 109(10):921-5. PubMed ID: 3899054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report of anesthesia for a child with Pompe's disease (glycogen storage disease type II)].
    Sakakibara M; Teramoto Y; Aoyama T; Takahashi T; Hara M; Maseki M; Yamaguchi S; Nakata J
    Masui; 2009 Feb; 58(2):219-22. PubMed ID: 19227183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K; Gröbe H; Korinthenberg R; von Bassewitz DB
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycogen storage disease (Pompe's disease) presenting as myopathy in the adult (author's transl)].
    Stefan H; Böker DK; Müller J; Gullotta F
    Dtsch Med Wochenschr; 1977 Oct; 102(42):1512-4. PubMed ID: 269788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy.
    Tanzer F; Buyukkayhan D; Cansu Mutlu E; Kalender Korkmaz F
    J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1159-62. PubMed ID: 20333876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered.
    El-Gharbawy AH; Bhat G; Murillo JE; Thurberg BL; Kampmann C; Mengel KE; Kishnani PS
    Mol Genet Metab; 2011 Aug; 103(4):362-6. PubMed ID: 21605996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyopathy in Pompe's disease.
    Fayssoil A
    Eur J Intern Med; 2008 Jan; 19(1):57-9. PubMed ID: 18206603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pompe's disease. Part II. Treatment strategies and enzyme replacement].
    Illés Z; Várdi Visy K
    Ideggyogy Sz; 2009 Sep; 62(9-10):299-307. PubMed ID: 19835271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended replacement of the thoracic aorta.
    Hino Y; Okada K; Oka T; Inoue T; Tanaka A; Omura A; Kano H; Okita Y
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):176-81; discussion 181. PubMed ID: 22723617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke in Young-Dilative Arteriopathy: A Clue to Late-Onset Pompe's Disease?
    Huded V; Bohra V; Prajapati J; DeSouza R; Ramankutty R
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):e50-2. PubMed ID: 26853144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.